The global Oral Trans-mucosal Drugs Market was valued at approximately USD 16.2 billion in 2023 and is projected to reach USD 35.7 billion by 2034, expanding at a CAGR of around 7.4%, driven by demand for fast-acting, non‑invasive drug delivery. With sublingual and buccal routes dominating, innovations in tablets, oral films, and sprays are enhancing applications in pain management, n... https://www.datamintelligence.com/research-report/oral-transmucosal-drugs-market